Will Johnson & Johnson Undercut Merck’s Bid to Buy Schering-Plough?
A 1998 change-of-control provision tied to Remicade complicates Merck’s attempted mega-merger.
A 1998 change-of-control provision tied to Remicade complicates Merck’s attempted mega-merger.